Revenue

Hilton Hawaiian Village's legendary Rainbow Tower gets a modern, art-infused refresh, blending 65 years of history with a strategic vision for the future.

MAX Power is shedding its lithium asset to go all-in on natural hydrogen. A look at the strategic choice that splits the energy transition in two.

The new collaboration embeds S&P Global's essential data into Cohere's secure AI platform, promising verifiable, agentic workflows for Wall Street.

A new documentary on a Silicon Valley engineer turned cricket hero reveals a calculated strategy: to win America's heart, you must first tell its stories.

Johnson & Johnson's acquisition of Firefly Bio for $1 billion signals a major push into degrader antibody conjugates, a new frontier for treating KRAS cancers.

The AvalonBay-Equity merger just named its leaders. It's not just a new C-suite; it's a blueprint for a tech-driven, $69B titan set on dominating the rental market.

In a rural California town, a new solar project is delivering more than clean power. It's building a lifeline—a permanent, state-of-the-art fire station.

A new alliance between tech firm Seequent and think tank Cascade Institute aims to map Canada's vast, untapped geothermal reserves using novel AI.

A digital health firm is trading millions in shares for a spot on the racetrack. A deep dive into the high-octane strategy to solve healthcare access.

A new campaign frames fusion energy as a U.S.-China security race. But beyond the hype, what is the reality of the global push for limitless power?

Dr. Brian Covino's top honor signals a shift in health tech, where AI doesn't replace doctors but learns from them. Can this model fix our broken system?

Septerna's novel oral drug for hypoparathyroidism could end the tyranny of injections and supplements, but its success hinges on a bigger bet: a new system for drugging life's most difficult molecular targets.

Amid market moderation, TerraCap's latest Florida acquisition highlights the enduring value of infill industrial assets and strategic capital improvements.

As rural hospitals face financial collapse, a new wave of AI-powered technology is proving it can stabilize finances and preserve access to essential care.

TelyRx just filled its millionth prescription, but the real story isn't the number. It's the 'operational innovation' of its cash-pay model that's disrupting healthcare.

Patagonia Gold celebrates first gold from its Calcatreu mine, a major operational win that ignites Argentina's Rio Negro economy amid deep-seated local dissent.

TOYO's landmark investment in a Houston HJT solar cell facility signals a new era for America's energy independence and high-efficiency manufacturing.

Beta Bionics faces a shareholder investigation after a slowdown in patient growth spooked investors. We decode the numbers and the broader risks of growth metrics.

With healthcare drowning in a $1 trillion administrative burden, CAQH's rebrand to DataSpring is more than a name change—it's a high-stakes bet.

With its new CryoTherm Palm, Therabody bets on thermoregulation to boost athletic power. We analyze the science, the strategy, and what it means for the future of wellness tech.